ECU Libraries Catalog

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...

Author/creator United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment
Format Book and Print
Publication InfoWashington : U.S. G.P.O., 1980-
Descriptionvolumes ; 23 cm
Subject(s)
Variant title New drug approval process
Variant title Orphan drugs
Contents v. 1. New drug approval process -- v. 2. Orphan drugs.
General noteVol. 1: "Food and Drug Administration regulation of research, development, and marketing of drugs, June 25, 1980."
General noteVol. 2: "How can we best use our limited resources and at the same time insure safe and effective drugs to diseases which occur infrequently, June 26, 1980."
General note"Serial no. 96-170."
General note"Serial no. 96-216."
Issued in other formOnline version: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment. Drug regulation reform--oversight. Washington : U.S.G.P.O., 1980-
Issued in other formOnline version: United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Health and the Environment. Drug regulation reform--oversight. Washington : U.S.G.P.O., 1980-
Technical rpt numberSerial No. 96-170 (United States. Congress. House. Committee on Interstate and Foreign Commerce)
Technical rpt numberSerial No. 96-216 (United States. Congress. House. Committee on Interstate and Foreign Commerce)
GPO item number1019
Govt. docs number Y 4.In 8/4:96-170
Govt. docs number Y 4.In 8/4:96-216

Available Items

Library Location Call Number Status Item Actions
Joyner Fed Docs Stacks Y 4.IN 8/4:96-170 ✔ Available Place Hold
Joyner Fed Docs Stacks Y 4.IN 8/4:96-216 ✔ Available Place Hold